PUTTING your back out can be excruciating though usually it’s nothing to worry about. But did you know that in some cases, ...

The Food and Drug Administration (FDA) has granted Fast Track designation to BRTX-100 for the treatment of chronic lumbar disc disease, defined as back and/or radicular pain with confirmed ...

Quiet weather today with bright skies & mild temperatures. Some rain at times tonight & Thursday. Any mix in northern Connecticut will not last long. Quiet during Friday with another weak system ...

Paul Alan Cox to Guam, where the researcher spoke with the indigenous Chamorro people of two different villages about a paralytic disease that ... in cyanobacteria and degenerative nerve diseases ...

Ask yourself, how do you elevate an existing approach in the marketing space? That’s the core tenet behind our strategy and is the driving force, for example, behind our latest campaign, Mild Mild ...

Every day, roughly 360 people in the U.S. begin treatment (either dialysis or a transplant) for kidney failure, according to the Centers for Disease Control and Prevention. A patient is considered ...

The “Wild to Mild” initiative launched in the fall of 2023 with imagery showing wild animals being reduced to cuter, cuddlier versions—a shark juxtaposed with a goldfish and a lion vs.

today announced that the U.S. Food and Drug Administration (“FDA”) has granted Fast Track designation to the BRTX-100 program for the treatment chronic lumbar disc disease (“cLDD”).

Phaistos Disc. Credit: C. Messier/Wikimedia Commons/CC-BY-SA-4.0 The Phaistos Disc, discovered in 1908 in Crete, has long been a subject of intrigue due to its undeciphered symbols arranged in a ...

A degenerative brain disease, CTE has been identified in athletes and military combat veterans who sustained concussions or repeated blows to the head. It can be diagnosed only posthumously ...

A recent case that shocked my team and I involved a groundskeeper whose access to long-term disability (LTD) benefits for degenerative disc disease was cut off at the two-year mark. The individual ...

AE: Did the fact that Cure Parkin­son’s is dedicated to curing a degenerative disease influence your approach to this generative project? MS: I have a strong childhood memory of a colleague of ...